Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial by Hida, Toyoaki, MD, Nokihara, Hiroshi, MD, Kondo, Masashi, MD, Kim, Young Hak, MD, Azuma, Koichi, MD, Seto, Takashi, MD, Takiguchi, Yuichi, Prof, Nishio, Makoto, MD, Yoshioka, Hiroshige, MD, Imamura, Fumio, MD, Hotta, Katsuyuki, Prof, Watanabe, Satoshi, MD, Goto, Koichi, MD, Satouchi, Miyako, MD, Kozuki, Toshiyuki, MD, Shukuya, Takehito, MD, Nakagawa, Kazuhiko, Prof, Mitsudomi, Tetsuya, Prof, Yamamoto, Nobuyuki, Prof, Asakawa, Takashi, PhD, Asabe, Ryoichi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial by Takahashi, Toshiaki, MD, Yamanaka, Takeharu, Prof, Seto, Takashi, MD, Harada, Hideyuki, MD, Nokihara, Hiroshi, MD, Saka, Hideo, MD, Nishio, Makoto, MD, Kaneda, Hiroyasu, MD, Takayama, Koichi, MD, Ishimoto, Osamu, MD, Takeda, Koji, MD, Yoshioka, Hiroshige, MD, Tachihara, Motoko, MD, Sakai, Hiroshi, MD, Goto, Koichi, MD, Yamamoto, Nobuyuki, Prof

Get full text

CH5424802 (RO5424802) for patients with ALK -rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study by Seto, Takashi, MD, Kiura, Katsuyuki, Prof, Nishio, Makoto, MD, Nakagawa, Kazuhiko, Prof, Maemondo, Makoto, MD, Inoue, Akira, MD, Hida, Toyoaki, MD, Yamamoto, Nobuyuki, MD, Yoshioka, Hiroshige, MD, Harada, Masao, MD, Ohe, Yuichiro, MD, Nogami, Naoyuki, MD, Takeuchi, Kengo, MD, Shimada, Tadashi, MS, Tanaka, Tomohiro, MS, Tamura, Tomohide, Dr

Get full text

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, rando... by Mitsudomi, Tetsuya, Dr, Morita, Satoshi, Prof, Yatabe, Yasushi, MD, Negoro, Shunichi, MD, Okamoto, Isamu, MD, Tsurutani, Junji, MD, Seto, Takashi, MD, Satouchi, Miyako, MD, Tada, Hirohito, MD, Hirashima, Tomonori, MD, Asami, Kazuhiro, MD, Katakami, Nobuyuki, MD, Takada, Minoru, Prof, Yoshioka, Hiroshige, MD, Shibata, Kazuhiko, MD, Kudoh, Shinzoh, MD, Shimizu, Eiji, Prof, Saito, Hiroshi, MD, Toyooka, Shinichi, MD, Nakagawa, Kazuhiko, Prof, Fukuoka, Masahiro, Prof

Get full text

Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma by Hazama, Daisuke, Nakahama, Kenji, Kodama, Hiroaki, Miyazaki, Akito, Azuma, Koichi, Kawashima, Yosuke, Sato, Yuki, Ito, Kentaro, Shiraishi, Yoshimasa, Miura, Keita, Takahama, Takayuki, Oizumi, Satoshi, Namba, Yoshinobu, Ikeda, Satoshi, Yoshioka, Hiroshige, Tsuya, Asuka, Yasuda, Yuichiro, Negi, Yoshiki, Hara, Ayako, Toda, Michihito, Tachihara, Motoko

Get full text

Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA... by Murata, Yasunori, Tanzawa, Shigeru, Misumi, Toshihiro, Yoshioka, Hiroshige, Miyauchi, Eisaku, Ninomiya, Kiichiro, Takeshita, Masafumi, Ito, Kensaku, Okamoto, Tatsuro, Sugawara, Shunichi, Kawashima, Yosuke, Hashimoto, Kazuki, Mori, Masahide, Miyanaga, Akihiko, Hayashi, Anna, Tanaka, Hisashi, Honda, Ryoichi, Nojiri, Masafumi, Sato, Yuki, Hata, Akito, Masuda, Ken, Kozuki, Toshiyuki, Kawamura, Takahisa, Suzuki, Takuji, Yamaguchi, Teppei, Asada, Kazuhiro, Tetsumoto, Satoshi, Tanaka, Hiroshi, Watanabe, Satoshi, Umeda, Yukihiro, Yamaguchi, Kakuhiro, Kuyama, Shoichi, Tsuruno, Kosuke, Misumi, Yuki, Kuraishi, Hiroshi, Yoshihara, Ken, Nakao, Akira, Kubo, Akihito, Yokoyama, Toshihiko, Watanabe, Kana, Seki, Nobuhiko

Get full text

Reenlargement of radiation necrosis after stereotactic radiotherapy for brain metastasis from lung cancer during bevacizumab treatment by Furuuchi, Koji, MD, Nishiyama, Akihiro, MD, Yoshioka, Hiroshige, MD, PhD, Yokoyama, Toshihide, MD, Ishida, Tadashi, MD, PhD

Get full text